Enhance your nephrology practice with CME and tools focused on kidney medicine.
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Leonie Kraft, MD
Improving Sleep and Mental Health in Patients with CKD-aP
CKD-aP Treatment Tool Kit
Elevating CKD-aP Care: New Frontier
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
Is CKD-aP Hiding in Your Dialysis Center?
The Patient-Clinician Connection in Managing CKD-aP
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Javed Butler, MD, MPH, MBA
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Patrick Rossignol, MD, PhD
Potassium Binders: Safety Comes First!
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.